1. Home
  2. JF vs SNSE Comparison

JF vs SNSE Comparison

Compare JF & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J and Friends Holdings Limited American Depositary Shares

JF

J and Friends Holdings Limited American Depositary Shares

N/A

Current Price

$1.00

Market Cap

14.3M

Sector

N/A

ML Signal

N/A

Logo Sensei Biotherapeutics Inc.

SNSE

Sensei Biotherapeutics Inc.

HOLD

Current Price

$9.10

Market Cap

12.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JF
SNSE
Founded
2012
2005
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3M
12.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
JF
SNSE
Price
$1.00
$9.10
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$72.50
AVG Volume (30 Days)
46.8K
55.1K
Earning Date
09-19-2025
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,961,892.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.20
N/A
52 Week Low
$0.82
$5.00
52 Week High
$1.38
$18.35

Technical Indicators

Market Signals
Indicator
JF
SNSE
Relative Strength Index (RSI) 49.14 44.76
Support Level $0.90 $8.72
Resistance Level $1.01 $9.56
Average True Range (ATR) 0.06 0.73
MACD 0.00 -0.11
Stochastic Oscillator 47.74 34.29

Price Performance

Historical Comparison
JF
SNSE

About JF J and Friends Holdings Limited American Depositary Shares

J and Friends Holdings Ltd, formerly Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

Share on Social Networks: